Sign in
CompletedNo phase

Concept Elicitation and Patient Experience Mapping in SA-AKI

Key facts

Who runs it
Novartis Pharmaceuticals
Where
East Hanover, United StatesSee the site
Trial code
Status
Completed
People taking part
28 people enrolled
Started
1 May 2025
Ended
30 Sept 2025
Type of study
Observational
Record updated
12 December 2025

Who can take part

Age
18 years to 85 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Potential participants who were diagnosed with SA-AKI (KDIGO stage I, II or III) must meet the following eligibility criteria:
  • ≥18 to ≤ 85 years of age
  • First diagnosis of SA-AKI at least 6 months prior to screening date, but no more than 10 years
  • Admitted due to sepsis and/or AKI to intensive care unit (ICU), intermediate care unit (IMCU), or high-dependency care unit, or developed sepsis and/or AKI during their inpatient hospital stay
  • Resident of country of study (US or Germany)
  • Access to computer, tablet, or smartphone with internet connection
  • Willing to participate in an audio recorded interview; Participants will be required to present confirmation of diagnosis (COD) rather than relying on a self-reported diagnosis. Sepsis and AKI diagnoses will be confirmed through one of the following:
  • Copy of medical records (e.g., portable document format [PDF] file of electronic health record)
  • Physician confirmation of diagnosis of sepsis and AKI (post-sepsis); Potential caregiver participants must meet the following criteria:
  • ≥18 to ≤ 85 years of age
  • Primary caregiver/care-partner for eligible participant who experienced SA-AKI
  • Resident of country of study (US or Germany)
  • Access to computer, tablet, or smartphone with internet connection
  • Willing to participate in an audio recorded interview

Who cannot take part

  • Less than age of majority in locality (Participant is not considered an adult in their country or region)
  • Potential participants are not eligible if they meet any of the following criteria:
  • Not willing to participate in an audio recorded interview
  • Not able to participate in the interview or complete required study surveys, based on the discretion of the study team

Where in United States

  • East Hanover, New JerseyHospital not named in the registry

About the trial

What the trial wants to find out

This is a concept elicitation study on patient's experiences of Sepsis-associated Acute Kidney Injury (SA-AKI)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Concept Elicitation and Patient Experience Mapping in Sepsis-associated Acute Kidney Injury
Record updated
12 December 2025